CAMP4 Therapeutics Corporation Common Stock (CAMP)
PHARMACEUTICAL PREPARATIONS
CAMP4 Therapeutics Corporation Common Stock (CAMP) is listed on Nasdaq, where it has traded since October 11, 2024.
- Listed On
- Nasdaq
- Listed Since
- October 11, 2024
- Employees
- 48
- Market Cap
- $246M
About CAMP4 Therapeutics Corporation Common Stock
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 59 institutions reported holding CAMP, with 41.7 million shares worth $182.2 million in aggregate. The largest reported holder was Jupiter Topco, with 6.3 million shares worth $27.6 million. Of the 5 largest holders listed below, 1 opened a new position in CAMP, 2 reduced their positions and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Jupiter Topco | 6,307,636 | $28M | New position |
| 5am Venture Management | 5,869,091 | $26M | Unchanged |
| FMR | 4,904,339 | $21M | Reduced 0.59% |
| Vivo Capital | 4,246,568 | $19M | Unchanged |
| Balyasny Asset Management | 2,575,724 | $11M | Reduced 2.15% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is CAMP?
CAMP4 Therapeutics Corporation Common Stock (CAMP) is listed on Nasdaq, where it has traded since October 11, 2024.
Who are the largest institutional holders of CAMP?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of CAMP were Jupiter Topco, 5am Venture Management and FMR.
How many institutions own CAMP?
59 institutions reported a position in CAMP for the quarter ended June 30, 2026, worth $182.2 million in total.
Did institutions buy or sell CAMP last quarter?
Of the 5 largest reported holders, 1 opened a new position in CAMP, 2 reduced their positions and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for CAMP.
Every reported institutional holder, plus insider and congressional trades in CAMP, on SentiSense.